Charytonowicz E - Search Results

1

p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients.

Zeng ZS, Sarkis AS, Zhang ZF, Klimstra DS, Charytonowicz E, Guillem JG, Cordon-Cardo C, Cohen AM. Zeng ZS, et al. Among authors: charytonowicz e. J Clin Oncol. 1994 Oct;12(10):2043-50. doi: 10.1200/JCO.1994.12.10.2043. J Clin Oncol. 1994. PMID: 7931472 Clinical Trial.

2

Family history of cancer, body weight, and p53 nuclear overexpression in Duke's C colorectal cancer.

Zhang ZF, Zeng ZS, Sarkis AS, Klimstra DS, Charytonowicz E, Pollack D, Vena J, Guillem J, Marshall JR, Cordon-Cardo C, et al. Zhang ZF, et al. Among authors: charytonowicz e. Br J Cancer. 1995 Apr;71(4):888-93. doi: 10.1038/bjc.1995.171. Br J Cancer. 1995. PMID: 7710960 Free PMC article.

3

Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors.

Cordon-Cardo C, Zhang ZF, Dalbagni G, Drobnjak M, Charytonowicz E, Hu SX, Xu HJ, Reuter VE, Benedict WF. Cordon-Cardo C, et al. Among authors: charytonowicz e. Cancer Res. 1997 Apr 1;57(7):1217-21. Cancer Res. 1997. PMID: 9102201

4

Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.

Lu ML, Wikman F, Orntoft TF, Charytonowicz E, Rabbani F, Zhang Z, Dalbagni G, Pohar KS, Yu G, Cordon-Cardo C. Lu ML, et al. Among authors: charytonowicz e. Clin Cancer Res. 2002 Jan;8(1):171-9. Clin Cancer Res. 2002. PMID: 11801555

5

Prognostic significance of p27Kip1 expression in bladder cancer.

Rabbani F, Koppie TM, Charytonowicz E, Drobnjak M, Bochner BH, Cordon-Cardo C. Rabbani F, et al. Among authors: charytonowicz e. BJU Int. 2007 Aug;100(2):259-63. doi: 10.1111/j.1464-410X.2007.06927.x. Epub 2007 Jun 6. BJU Int. 2007. PMID: 17555476

6

Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network.

Lianes P, Charytonowicz E, Cordon-Cardo C, Fradet Y, Grossman HB, Hemstreet GP, Waldman FM, Chew K, Wheeless LL, Faraggi D. Lianes P, et al. Among authors: charytonowicz e. Clin Cancer Res. 1998 May;4(5):1267-71. Clin Cancer Res. 1998. PMID: 9607586

7

Gene discovery in bladder cancer progression using cDNA microarrays.

Sanchez-Carbayo M, Socci ND, Lozano JJ, Li W, Charytonowicz E, Belbin TJ, Prystowsky MB, Ortiz AR, Childs G, Cordon-Cardo C. Sanchez-Carbayo M, et al. Among authors: charytonowicz e. Am J Pathol. 2003 Aug;163(2):505-16. doi: 10.1016/S0002-9440(10)63679-6. Am J Pathol. 2003. PMID: 12875971 Free PMC article.

8

Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome.

Sanchez-Carbayo M, Schwarz K, Charytonowicz E, Cordon-Cardo C, Mundel P. Sanchez-Carbayo M, et al. Among authors: charytonowicz e. Oncogene. 2003 Aug 14;22(34):5298-305. doi: 10.1038/sj.onc.1206616. Oncogene. 2003. PMID: 12917631

9

Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization.

Rabbani F, Richon VM, Orlow I, Lu ML, Drobnjak M, Dudas M, Charytonowicz E, Dalbagni G, Cordon-Cardo C. Rabbani F, et al. Among authors: charytonowicz e. J Natl Cancer Inst. 1999 May 19;91(10):874-81. doi: 10.1093/jnci/91.10.874. J Natl Cancer Inst. 1999. PMID: 10340908

10

Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes.

Sanchez-Carbayo M, Socci ND, Charytonowicz E, Lu M, Prystowsky M, Childs G, Cordon-Cardo C. Sanchez-Carbayo M, et al. Among authors: charytonowicz e. Cancer Res. 2002 Dec 1;62(23):6973-80. Cancer Res. 2002. PMID: 12460915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters